Contents
Download PDF
pdf Download XML
49 Views
14 Downloads
Share this article
Research Article | Volume 16 Issue 11 (November, 2026) | Pages 92 - 94
The Association Between Serum Procalcitonin Levels And Severity Of Coronary Artery Disease Assessed By Syntax Score In Patients With Acute Coronary Syndrome
 ,
 ,
1
Assistant Professor, Department of Cardiology, SCB Medical College and Hospital, Cuttack, Odisha,
2
Associate Professor, Department of Orthopedic PRM Medical College and Hospital, Baripada, Odisha,
3
Assistant Professor, Department of Anaesthesiology,SCB Medical College and Hospital, Cuttack, Odisha,
Under a Creative Commons license
Open Access
Received
Oct. 12, 2026
Revised
Oct. 25, 2026
Accepted
Nov. 1, 2026
Published
Nov. 19, 2026
Abstract

Background: Acute coronary syndrome (ACS) remains a global health challenge driven by atherosclerosis and plaque instability. While traditionally known as a biomarker for bacterial infections, serum procalcitonin (PCT) has increasingly been recognized for its role in systemic inflammation, including cardiovascular events. This study evaluates the relationship between serum procalcitonin levels and the anatomical severity of coronary artery disease (CAD)—quantified by the SYNTAX score—in patients presenting with ACS. Methods: We conducted a prospective observational study at SCB Medical College and Hospital (SCB MCH), Cuttack, spanning a one-year period from March 2025 to March 2026. A total of 98 patients admitted with a diagnosis of ACS and who were scheduled for coronary angiography were enrolled. Admission serum PCT levels and other routine biomarkers were collected. The SYNTAX score was calculated for each patient to determine CAD severity, categorizing patients into low/intermediate (≤22) and high (>22) severity groups. Results: Among the 98 participants, the mean age was 59.2 ± 10.5 years, and a majority were male (68.4%). Patients in the high SYNTAX score group (>22) exhibited significantly elevated serum PCT levels (median 0.15 ng/mL) compared to those in the low/intermediate group (median 0.04 ng/mL), with a statistically significant p-value (<0.001). A strong, positive correlation was identified between admission serum PCT levels and the calculated SYNTAX score (r = 0.62, p < 0.01). Furthermore, multivariate analysis confirmed that a PCT level of >0.10 ng/mL was an independent predictor of a high SYNTAX score. Conclusion: Serum procalcitonin levels are significantly elevated in ACS patients with severe coronary artery disease. Because PCT strongly correlates with the SYNTAX score, it has the potential to be a non-invasive, accessible clinical tool for early risk stratification and assessing CAD severity in acute care settings.

Keywords
INTRODUCTION

Acute coronary syndrome (ACS) is the most severe manifestation of coronary artery disease (CAD), representing a spectrum of conditions ranging from unstable angina (UA) to non-ST-segment elevation myocardial infarction (NSTEMI) and ST-segment elevation myocardial infarction (STEMI). At the core of ACS pathogenesis lies chronic inflammation, which accelerates atherosclerosis, destabilizes plaques, and provokes thrombosis.

 

While C-reactive protein (CRP) has long been the gold standard inflammatory marker in cardiology, recent research has pivoted toward exploring alternative biomarkers that might offer better prognostic value. Serum procalcitonin (PCT), the 116-amino acid precursor of the hormone calcitonin, is primarily recognized for its drastic elevation during severe bacterial infections and sepsis. However, mild to moderate elevations in PCT are also observed in non-infectious systemic inflammatory states, such as extensive tissue injury and cardiogenic shock.

 

The SYNTAX score is an angiographic tool used to grade the complexity of CAD. It helps guide the choice of revascularization strategy—either percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). Since calculating the SYNTAX score requires invasive coronary angiography, identifying a reliable, non-invasive biomarker that can predict CAD severity would be highly beneficial for triaging patients.

 

This study aimed to evaluate the association between admission serum PCT levels and the angiographic severity of CAD, measured by the SYNTAX score, in patients presenting with ACS at a tertiary care center in Odisha.

MATERIALS AND METHODS

2.1 Study Design and Setting

This was a single-center, prospective observational study conducted at the Department of Cardiology, SCB Medical College and Hospital (SCB MCH), Cuttack. The study period extended from March 2025 to March 2026.

 

 

2.2 Study Population

The study included 98 adult patients (age ≥ 18 years) admitted to the cardiac emergency or intensive care unit with a confirmed diagnosis of ACS who subsequently underwent coronary angiography. Patients were excluded if they had active systemic infections, sepsis, severe renal impairment, chronic inflammatory diseases, active malignancies, or recent major surgery, as these conditions independently raise PCT levels.

 

2.3 Data Collection and Laboratory Analysis

Peripheral venous blood samples were drawn upon admission before any invasive procedures. Serum PCT was analyzed using an automated electrochemiluminescence immunoassay. Standard protocols were followed to assess lipid profiles, cardiac troponins, and high-sensitivity C-reactive protein (hs-CRP).

 

2.4 Angiographic Assessment (SYNTAX Score)

Diagnostic coronary angiography was performed by experienced interventional cardiologists via the transradial or transfemoral approach. The SYNTAX score was calculated using the official online calculator based on the location and characteristics of all coronary lesions causing ≥50% luminal narrowing in vessels ≥1.5 mm in diameter. Based on the score, patients were divided into two groups:

 

·         Group A: Low/Intermediate SYNTAX Score (≤ 22)

·         Group B: High SYNTAX Score (> 22)

 

2.5 Statistical Analysis

Statistical analysis was carried out using appropriate software. Continuous variables were expressed as mean ± standard deviation (SD) or median with interquartile range (IQR), and compared using the Student's t-test or Mann-Whitney U test. Categorical variables were expressed as frequencies and percentages, analyzed by the Chi-square test. Correlation was evaluated using Pearson or Spearman rank coefficients. A p-value of <0.05 was considered statistically significant.

 

RESULTS

Table 1: Baseline Demographic and Clinical Characteristics (n=98)

Characteristic

Low/Intermediate SYNTAX (≤22) (n=62)

High SYNTAX (>22) (n=36)

p-value

Age (years), Mean ± SD

57.4 ± 9.8

62.1 ± 10.4

0.034*

Male Gender, n (%)

41 (66.1%)

26 (72.2%)

0.528

Hypertension, n (%)

35 (56.4%)

28 (77.7%)

0.038*

Diabetes Mellitus, n (%)

24 (38.7%)

22 (61.1%)

0.033*

Active Smoking, n (%)

29 (46.7%)

20 (55.5%)

0.407

 

Description: Patients in the high SYNTAX score group were slightly older and had a significantly higher prevalence of hypertension and diabetes compared to the low/intermediate group. Gender and smoking status did not show statistically significant differences.

 

Table 2: Clinical Presentation of Acute Coronary Syndrome

Presentation Type

Low/Intermediate SYNTAX (n=62)

High SYNTAX (n=36)

p-value

Unstable Angina (UA)

12 (19.3%)

3 (8.3%)

0.141

NSTEMI

22 (35.5%)

8 (22.2%)

0.165

STEMI

28 (45.2%)

25 (69.4%)

0.021*

 

Description: The majority of patients presenting with a High SYNTAX score had a diagnosis of STEMI (69.4%), which was significantly higher than the proportion in the Low/Intermediate group (45.2%).

 

Table 3: Laboratory Biomarkers and Lipid Profiles

Biomarker

Low/Intermediate SYNTAX (≤22)

High SYNTAX (>22)

p-value

Total Cholesterol (mg/dL)

185.4 ± 35.2

202.6 ± 40.1

0.031*

LDL Cholesterol (mg/dL)

122.5 ± 28.4

145.2 ± 30.6

<0.001*

hs-CRP (mg/L)

3.2 ± 1.5

6.8 ± 2.9

<0.001*

Serum Procalcitonin (ng/mL)

0.04 (0.02-0.08)

0.15 (0.10-0.28)

<0.001*

 

Description: Inflammatory and lipid biomarkers were significantly elevated in the high SYNTAX group. Notably, median serum PCT levels were almost four times higher in patients with severe CAD.

 

Table 4: Correlation Between Serum Biomarkers and SYNTAX Score

Variable

Correlation Coefficient (r)

95% Confidence Interval

p-value

Age

0.22

0.02 to 0.40

0.029*

LDL Cholesterol

0.38

0.20 to 0.54

<0.001*

hs-CRP

0.45

0.28 to 0.60

<0.001*

Serum Procalcitonin

0.62

0.48 to 0.73

<0.001*

 

Description: A strong positive correlation was observed between the SYNTAX score and serum Procalcitonin (r = 0.62), signifying that higher PCT levels are closely linked to greater anatomical complexity of coronary lesions.

 

Table 5: Multivariate Regression Analysis for Predictors of High SYNTAX Score (>22)

Predictor Variable

Odds Ratio (OR)

95% Confidence Interval

p-value

Age > 60 years

1.85

0.95 - 3.60

0.071

Diabetes Mellitus

2.30

1.12 - 4.75

0.023*

hs-CRP > 5 mg/L

3.15

1.45 - 6.80

0.004*

Procalcitonin > 0.10 ng/mL

4.80

2.10 - 10.95

<0.001*

 

Description: In the multivariate model adjusting for traditional risk factors, serum Procalcitonin > 0.10 ng/mL emerged as the strongest independent predictor for a high SYNTAX score (OR 4.80, p<0.001).

DISCUSSION

The primary finding of this study conducted at SCB MCH, Cuttack, is that elevated admission serum procalcitonin levels are strongly associated with the angiographic severity of coronary artery disease in patients with ACS. Among our cohort of 98 patients, those with highly complex coronary lesions (SYNTAX score > 22) demonstrated substantially higher PCT levels compared to those with lower scores. Our results align with the growing body of evidence highlighting the role of systemic inflammation in atherosclerosis. While PCT is widely utilized to rule out bacterial sepsis, its mild elevation in ACS suggests an intense, sterile inflammatory response triggered by myocardial ischemia and necrosis. This inflammatory cascade contributes to plaque vulnerability and widespread coronary involvement. We found a robust correlation (r = 0.62) between PCT and the SYNTAX score, which was stronger than the correlation seen with hs-CRP. The multivariate analysis further cemented PCT as an independent predictor of severe CAD. This suggests that incorporating PCT testing in the emergency department could help clinicians identify patients who might require more aggressive pharmacological intervention or complex revascularization strategies.

 

Limitations: The sample size of 98 patients from a single center (SCB MCH) may limit the broad generalizability of the findings. The study period was restricted to one year (March 2025 to March 2026). Furthermore, serial PCT measurements were not conducted, which could have provided insight into the temporal dynamics of this biomarker post-ACS.

CONCLUSION

Serum procalcitonin is a promising, non-invasive biomarker that reflects the anatomical severity of coronary artery disease in patients presenting with acute coronary syndrome. Elevated levels are significantly associated with a high SYNTAX score. Routine measurement of PCT on admission could serve as a valuable adjunctive tool for risk stratification, helping cardiologists tailor early interventional strategies.

REFERENCES

1.       Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019;40(3):237-269.

2.       Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352(16):1685-1695.

3.       Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005;1(2):219-227.

4.       Muller B, White JC, Nylén ES, Snider RH, Becker KL, Habener JF. Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab. 2001;86(1):396-404.

5.       Sinning CR, Sinning JM, Schulz A, et al. Association of serum procalcitonin with cardiovascular prognosis in coronary artery disease. Circ Cardiovasc Genet. 2011;4(3):322-328.

6.       Kelly D, Squire IB, Khan SQ, et al. C-reactive protein, procalcitonin, and the prediction of mortality in patients with acute myocardial infarction. Biomarkers. 2010;15(4):325-331.

7.       Senturk T, Cordan J, Baran I, et al. Procalcitonin in patients with acute coronary syndrome: correlation with high-sensitive C-reactive protein and SYNTAX score. Herz. 2014;39(7):851-857.

8.       Kurtul A, Yarlioglues M, Celik IE, et al. Association of serum procalcitonin levels with severity of coronary artery disease assessed by SYNTAX score in patients with acute coronary syndrome. Int J Cardiol. 2015;184:581-585.

9.       Rhee JW, Sabatine MS, Lilly LS. Acute coronary syndromes. In: Pathophysiology of Heart Disease. 6th ed. Wolters Kluwer; 2016:162-189.

10.    Meisell AJ, Trost JC. Biomarkers in acute coronary syndrome. Cardiol Clin. 2018;36(1):1-10.

11.    O'Donoghue M, Morrow DA, Cannon CP, et al. Multimarker risk stratification in patients with acute myocardial infarction. J Am Coll Cardiol. 2006;48(5):852-861.

12.    Erdinler I, Kocas C, Abaci O, et al. The role of procalcitonin as a predictor of coronary artery disease severity in stable angina pectoris. Coron Artery Dis. 2016;27(3):192-196.

13.    Karakas M, Januzzi JL, Meyer Z, et al. Procalcitonin and cardiovascular events. J Am Heart Assoc. 2020;9(4):e014761.

14.    Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868-874.

15.    Garg S, Serruys PW. SYNTAX score evolution and future directions. Nat Rev Cardiol. 2010;7(11):616-621.

Recommended Articles
Original Article
Diagnostic Accuracy of Coronary CT Angiography Against Invasive Coronary Angiography in Haemodynamically Stable, Low-Risk Unstable Angina and NSTEMI: A Prospective Observational Study from a Tertiary Referral Centre in India
Published: 19/11/2026
Download PDF
Research Article
Early Outcomes Of Total Arterial Coronary Artery Bypass Grafting: A Retrospective Institutional Analysis
...
Published: 19/11/2026
Download PDF
Research Article
Time Course Of Left Ventricular Functional Recovery After Coronary Artery Bypass Grafting In Patients With Severe Lv Dysfunction: A Retrospective Echocardiographic Study
...
Published: 19/11/2026
Download PDF
Research Article
Comparative Evaluation of Cognitive Function in Patients with Schizophrenia Versus Bipolar Disorder: A Cross-Sectional Study
Published: 14/04/2024
Download PDF
Chat on WhatsApp
Copyright © EJCM Publisher. All Rights Reserved.